ARVINDSELVAN MOHANASELVAN: Open Payments
NPI 1316472400 · LOS BANOS, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$533 in 31 payments from 10 companies in 2025. Trend: 2023 $453 · 2024 $977 · 2025 $533
Food & beverage: $533
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 15 | $148 |
| AstraZeneca Pharmaceuticals LP | 3 | $145 |
| PFIZER INC. | 4 | $68 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $45 |
| Astellas Pharma US Inc | 2 | $38 |
| Abbott Laboratories | 1 | $23 |
| Novo Nordisk Inc | 1 | $18 |
| Dexcom, Inc. | 1 | $17 |
| Merck Sharp & Dohme LLC | 1 | $16 |
| Exact Sciences Corporation | 1 | $15 |
Products named: JARDIANCE, BREZTRI, NURTEC ODT, XIFAXAN, Veozah, FARXIGA, FREESTYLE LIBRE 3, AIRSUPRA.
Industry payments across CA — which companies pay providers there.
